TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP. October 28, 2005
TCL Archive In Brief: Cancer Program A “Noble Venture,” Kennedy Says; $937 Million Not Enough, Upton Says April 13, 1979